SL
Swarna Latha Pagadala
About Swarna Latha Pagadala
Data last updated:
Swarna Latha Pagadala is a Director at Rovertis Pharmaceuticals Private Limited (since 2004). The company operates in Healthcare. Rovertis Pharmaceuticals Private Limited reported revenue of ₹63.3 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Oct 2004 | 2004 | ₹63.3 Lakh (FY 2023) | Active |
Board colleagues of Swarna Latha Pagadala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Krishnam Raju Vegesna | 02060145 | Rovertis Pharmaceuticals Private Limited | Director |
| Padma Rajaboina | 02167715 | Rovertis Pharmaceuticals Private Limited | Director |
| Rajitha Rajaboina | 03335704 | Rovertis Pharmaceuticals Private Limited | Director |
| Sreenivasa Rao Devarakonda | 03334241 | Rovertis Pharmaceuticals Private Limited | Director |
| Swarupa Rani Chintala | 02167652 | Rovertis Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swarna Latha Pagadala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swarna Latha Pagadala
Swarna Latha Pagadala currently holds 1 directorship: Rovertis Pharmaceuticals Private Limited (Director, since 04 Oct 2004, revenue ₹63.3 Lakh (FY 2023)).
Swarna Latha Pagadala was first appointed on 04 Oct 2004 as Director at Rovertis Pharmaceuticals Private Limited.
The current boards of Swarna Latha Pagadala's companies include Krishnam Raju Vegesna (Rovertis Pharmaceuticals Private Limited), Padma Rajaboina (Rovertis Pharmaceuticals Private Limited), Rajitha Rajaboina (Rovertis Pharmaceuticals Private Limited), Sreenivasa Rao Devarakonda (Rovertis Pharmaceuticals Private Limited), Swarupa Rani Chintala (Rovertis Pharmaceuticals Private Limited).